Patent details

Basic Information

Publication number:

EP1478358

PCT Application Number:

PCT/US/2003/004103

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP037078466

PCT Publication Number:

WO/2003/068228

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis

French Title of Invention:

Tosylate de sorafenib pour le traitement des maladies caractérisées par une angiogénèse anormale

German Title of Invention:

Sorafenib Tosylate zur Behandlung von durch unnormale Angiogenese gekennzeichneten Krankheiten

SPC Number:

Dates

Filing date:

11/02/2003

Grant date:

03/07/2013

EP Publication Date:

03/07/2013

PCT Publication Date:

21/08/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/11/2004

EP B1 Publication Date:

03/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/02/2023

Renunciation date:

Revocation date:

09/03/2016

Annulment date:

Owner

From:

20/02/2015

 

 

Name:

Bayer HealthCare LLC

Address:

100 Bayer Boulevard, Whippany, NJ 07981, United States (US)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

14/08/2013

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

ELTING James

Address:

United States (US)

2

Name:

HATOUM-MAKDAD Holia

Address:

United States (US)

3

Name:

DUMAS Jacques

Address:

United States (US)

4

Name:

SCOTT William, J.

Address:

United States (US)

Priority

Priority Number:

354950 P

Priority Date:

11/02/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/44;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

25/01/2016

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages